Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Novavax Stock Is Rising Today

TheMotleyFool

0 0

Shares of Novavax (NASDAQ: NVAX) were rising 4.2% higher as of 11:42 a.m. ET on Thursday after climbing as much as 7% earlier in the day. The gain came after the company announced that its partner, Takeda Pharmaceutical (NYSE: TAK), has filed for approval of Novavax's COVID-19 vaccine in Japan.

Regulatory submission in Japan is an important milestone for Novavax. The Japanese government has committed to purchasing 150 million doses of NVX-CoV2373 (known as TAK-019 in Japan) if it wins approval. The financial terms of this supply agreement weren't announced. However, it's safe to say that Novavax could make a significant amount of money if its vaccine wins Japanese approval.

Image source: Getty Images.

Source Fool.com

Like: 0

NVAX

Share